ValiRx PLC Holding(s) in Company (9770W)
20 November 2017 - 10:23PM
UK Regulatory
TIDMVAL
RNS Number : 9770W
ValiRx PLC
20 November 2017
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to
the relevant issuer and to the FCA in Microsoft
Word format if possible)(i)
---------------------------------------------------------------------------------------------
1a. Identity of the issuer Valirx PLC
or the underlying issuer
of existing shares to
which voting rights are
attached(ii) :
---------------------------------------- ---------------------------------------------------
1b. Please indicate if the issuer is a non-UK
issuer (please mark with an "X" if appropriate)
---------------------------------------------------------------------------------------------
Non-UK issuer
--------------------------------------------------------------------------- ----------------
2. Reason for the notification (please mark
the appropriate box or boxes with an "X")
---------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights x
--------------------------------------------------------------------------- ----------------
An acquisition or disposal of financial instruments
--------------------------------------------------------------------------- ----------------
An event changing the breakdown of voting
rights
--------------------------------------------------------------------------- ----------------
Other (please specify)(iii) :
--------------------------------------------------------------------------- ----------------
3. Details of person subject to the notification
obligation(iv)
---------------------------------------------------------------------------------------------
Name NICHOLAS SLATER
---------------------------------------- ---------------------------------------------------
City and country of registered LONDON
office (if applicable)
---------------------------------------- ---------------------------------------------------
4. Full name of shareholder(s) (if different
from 3.)(v)
---------------------------------------------------------------------------------------------
Name
---------------------------------------- ---------------------------------------------------
City and country of registered
office (if applicable)
---------------------------------------- ---------------------------------------------------
5. Date on which the threshold 16/11/2017
was crossed or reached(vi)
:
---------------------------------------- ---------------------------------------------------
6. Date on which issuer 20/11/2017
notified (DD/MM/YYYY):
---------------------------------------- ---------------------------------------------------
7. Total positions of person(s) subject to the
notification obligation
---------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights
(total of instruments of issuer(vii)
8. A) (total
of 8.B 1
+ 8.B 2)
------------------ -------------------- ---------------- --------------- ----------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 2.7% 2.7% 203958937
------------------ -------------------- ---------------- --------------- ----------------
Position
of previous
notification
(if
applicable) 3.48% 3.48% 203958937
------------------ -------------------- ---------------- --------------- ----------------
8. Notified details of the resulting situation
on the date on which the threshold was crossed
or reached(viii)
----------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------
Class/type Number of voting % of voting rights
of rights(ix)
shares
ISIN code
(if possible)
----------------- --------------------------------- ----------------------------------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 (Art 9 of (Art 10 of
Directive of Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
---------------- ----------------- -------------- ------------------------------ --------------
GB00BWWYSP41 5490112 2.7%
----------------- ----------------- -------------- ------------------------------ --------------
SUBTOTAL
8. A 5490112 2.7%
----------------- --------------------------------- ----------------------------------------------
B 1: Financial Instruments according to Art.
13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1
(a))
----------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of % of voting
financial date(x) Conversion voting rights rights
instrument Period(xi) that may be
acquired if
the instrument
is
exercised/converted.
----------------- ----------------- -------------- ------------------------------ --------------
SUBTOTAL
8. B 1
----------------- ----------------- -------------- ------------------------------ --------------
B 2: Financial Instruments with similar economic
effect according to Art. 13(1)(b) of Directive
2004/109/EC (DTR5.3.1.1 (b))
----------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
---------------- ------------------ -------------- ----------------- ----------- --------------
SUBTOTAL
8.B.2
----------------------------------- -------------- ----------------- ----------- --------------
9. Information in relation to the person subject
to the notification obligation (please mark
the
applicable box with an "X")
---------------------------------------------------------------------------------
Person subject to the notification obligation x
is not controlled by any natural person or
legal entity and does not control any other
undertaking(s) holding directly or indirectly
an interest in the (underlying) issuer(xiii)
---------------------------------------------------------- ---------------------
Full chain of controlled undertakings through
which the voting rights and/or the
financial instruments are effectively held
starting with the ultimate controlling natural
person or legal entity(xiv) (please add additional
rows as necessary)
---------------------------------------------------------- ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
----------- ------------------ ----------------------- -----------------------
10. In case of proxy voting, please identify:
---------------------------------------------------------------------------------
Name of the proxy holder
------------------------------- ------------------------------------------------
The number and % of voting
rights held
------------------------------- ------------------------------------------------
The date until which
the voting rights will
be held
------------------------------- ------------------------------------------------
11. Additional information(xvi)
---------------------------------------------------------------------------------
Place of completion LONDON
-------------------- -----------
Date of completion 20/11/2017
-------------------- -----------
The company news service from the London Stock Exchange
END
HOLURUARBAAAUAA
(END) Dow Jones Newswires
November 20, 2017 06:23 ET (11:23 GMT)
Valirx (LSE:VAL)
Historical Stock Chart
From Apr 2024 to May 2024
Valirx (LSE:VAL)
Historical Stock Chart
From May 2023 to May 2024